Results 1 to 6 of 6

Thread: Oncology question

  1. #1

    Wink Oncology question

    Oncology Question
    Need clarification on the proper way to code for infusion of the drug Heception J3955,
    96413 for 1:30 minutes of infusion.
    DX: Breast Cancer

    Scenarios one
    The reason for the encounter is for infusion of the herceptin drug for a one time visit.
    Scenarios two
    The reason for the encounter is for infusion of the herceptin drug for a series of visits
    Should the diagnosis be?
    V58.11
    1749

    Or
    V58.69
    174.9

    Or
    174.9
    V58.69

    Some supporting documents
    Coding Clinic, Third Quarter 2009, page 3 and 4
    States you should assign code 174.9 malignant neoplasm for the female breast, unspecified, as the first listed diagnosis, since Herceptin is considered cancer treatment. Assign code V58.69, long term use (current) use of Herceptin. It also states that Herceptin therapy is not antineoplastic chemotherapy, but is a biological adjuvant treatment for women with breast cancers that are HER2 positive

  2. #2
    Join Date
    Apr 2007
    Location
    Columbia, MO
    Posts
    11,481

    Default

    The coding clinic is correct. Herceptin is not chemo it is a biologic response modifier. We always coded it as the 174.9 with the V58.69.

    Debra A. Mitchell, MSPH, CPC-H

  3. #3
    Join Date
    Apr 2007
    Location
    Bettendorf, Iowa
    Posts
    125

    Default

    Herceptin is an antineoplastic drug which is also a monoclonal antibody, which is a fairly newer treatment concept in fighting cancer. It basically attaches itself to the HER2/neu receptor cells and prohibits them from proliferating, in addition to priming the patient's own immune system for attacking those specific malignant tumor cells.

    It IS considered a chemotherapy agent by industry standards. It is coded as a J9000 code by the American Medical Association listed under injectible chemotherapy drugs.

    While there are shades of gray in the world of oncology, with many policies and procedures being open for interpretation, my recommendation would be to use the V58.11 with the use of Herceptin.

    You should also be coding to the greatest specificity for breast cancer and only be using 174.9 if theres no other option. The coding clinic you are referencing is outdated.
    Last edited by relong; 07-25-2012 at 01:39 PM.
    Ruth Long CPC,CHONC
    relong@rccqc.com

  4. #4

    Default

    A couple of things I would like for you to clarify -

    Did you mean J9355 (J9000 is for Doxorubicin)?

    I was told at some point that "all the -mabs (which includes Herceptin) must be coded with V58.12". I've never been able to find anything in writing on this. Do you have in mind any reference source, that will give me a better understanding why V58.11 needs to be used instead of V58.12.

    Thank you -
    Lioubov Petrova, CPC, CHONC

  5. #5
    Join Date
    Apr 2007
    Location
    Bettendorf, IA
    Posts
    90

    Thumbs up

    Lioubov -
    I think what Ruth was trying to say was that all the J9XXX codes (J-Nine thousand codes) and not necessarily J9000 (Adriamycin) were considered chemotherapy drugs. As far as the V58.12 is concerned, you are probably correct regarding the -mabs, it would be the most specific code to use. As long as the V58.69, which is the LEAST specific code, is not used as suggested in the initial post, I think it's ok.
    Have a great rest of the week!
    Helene Roberts, CPC, CMIS, CHONC

  6. #6
    Join Date
    Apr 2007
    Posts
    23

    Default

    Quote Originally Posted by relong View Post
    Herceptin is an antineoplastic drug which is also a monoclonal antibody, which is a fairly newer treatment concept in fighting cancer. It basically attaches itself to the HER2/neu receptor cells and prohibits them from proliferating, in addition to priming the patient's own immune system for attacking those specific malignant tumor cells.

    It IS considered a chemotherapy agent by industry standards. It is coded as a J9000 code by the American Medical Association listed under injectible chemotherapy drugs.

    While there are shades of gray in the world of oncology, with many policies and procedures being open for interpretation, my recommendation would be to use the V58.11 with the use of Herceptin.

    You should also be coding to the greatest specificity for breast cancer and only be using 174.9 if theres no other option. The coding clinic you are referencing is outdated.
    RUTH: Would you know the most recen coding clinic? I could not find anything after the one quoted in this string. Please let me know.

Similar Threads

  1. Radiation Oncology Question
    By rachelb@leadingcancercare.com in forum Hematology/Oncology
    Replies: 2
    Last Post: 05-06-2014, 02:18 PM
  2. Oncology DX question
    By jennifervybiral in forum Diagnosis Coding
    Replies: 1
    Last Post: 03-23-2010, 09:25 AM
  3. oncology dx question
    By angied1980 in forum Diagnosis Coding
    Replies: 1
    Last Post: 11-24-2009, 12:37 PM
  4. Oncology coding question
    By cpccoder2008 in forum Hematology/Oncology
    Replies: 8
    Last Post: 08-28-2009, 07:12 PM
  5. Oncology question
    By rcbaker in forum Medical Coding General Discussion
    Replies: 0
    Last Post: 02-03-2009, 09:37 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •